Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel green method for delta-cyclopentanolide production using recyclable amino acid ionic liquids, offering cost reduction and high purity for pharma intermediates.
Novel copper-catalyzed C-F activation method offers high selectivity and mild conditions for producing difluoroalkenes, ensuring reliable supply chain stability.
Advanced water-based synthesis for 1,2,3-triazoles offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN116003312B reveals a metal-free boron catalysis method for meta-selective pyridine functionalization, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112679299B reveals a metal-free route to diarylmethanes using phosphorous acid and iodine, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed C-H bifunctionalization for nitrogen heterocycles. Enhances purity and supply chain reliability for pharma intermediates.
Patent CN112479876B details a novel chiral resolution method for oxazepane spiro compounds, offering improved stereoselectivity and streamlined manufacturing for global supply chains.
Patent CN113831366A discloses novel cinchona alkaloid ligands for high-efficiency asymmetric catalysis, offering superior stereoselectivity and scalable manufacturing for pharmaceutical intermediates.
Patent CN103193830A reveals a flexible route for chiral ferrocene phosphine ligands, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply.
Patent CN112939922B details a cost-effective synthesis route for a critical Mesotrione impurity, offering reliable supply chain solutions and high-purity standards for agrochemical registration.
Novel preparation method for Tezacaftor via reductive cyclization. High purity, low cost, scalable industrial process for API intermediates.
Novel BF3-catalyzed route offers high yields and metal-free purification for scalable API intermediate production.
Patent CN113373466A details a green electrochemical route for beta-acetaminocarbonyl compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112047797A reveals a green iridium-catalyzed method for alpha-alkyl ketones using water. Discover cost-effective manufacturing and supply advantages.
Patent CN112010896B reveals a green copper-catalyzed route for phosphonates, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN109705154B details a cobalt-catalyzed tandem hydrosilylation for synthesizing exo-gem-disilyl alkanes. This method offers superior regioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113956208A reveals a metal-free, Eosin Y-catalyzed arylation method offering cost reduction in pharmaceutical intermediate manufacturing and scalable green chemistry solutions.
Patent CN116589519A reveals improved sulfonation and Suzuki coupling for high-purity API intermediate manufacturing with reduced corrosion risks and enhanced scalability.
Novel zinc-mediated route for Vilazodone intermediate. High yield, low waste, scalable production for pharma supply chains ensuring reliability and cost efficiency globally for all buyers.
Novel C7-position stereospecific method enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally using cost effective ruthenium catalysis.